News & Updates

Join As Board

Dear Reviewer, You can join our Reviewer team without given any charges in our journal. Submit Details on below link: Join As Board

Submit Article

Dear Authors, Article publish in our journal for Volume-1,Issue-1. For article submission on below link: Submit Manuscript

PHYTOCHEMICAL AND PHARMACOLOGICAL ASSESSMENT OF THE HYPOLIPIDEMIC POTENTIAL OF CAESALPINIA BAHAMENSIS LEAF EXTRACT

Area: Department of Pharmacology
Abstract: Dyslipidaemia, characterised by elevated total cholesterol (TC), triglycerides (TG) and low-density lipoprotein cholesterol (LDL-C) together with depressed high-density lipoprotein cholesterol (HDL-C), remains one of the most important modifiable drivers of atherosclerotic cardiovascular disease worldwide. Although statins are clinically effective, intolerance, cost and poor adherence in resource-limited settings have renewed interest in plant-derived lipid-lowering agents. Caesalpinia bahamensis Lam. (Fabaceae), a Caribbean-endemic legume known locally as brasilete, accumulates homoisoflavonoids such as brazilin and protosappanin B, together with flavonoids, tannins and saponins, and is used traditionally for metabolic and inflammatory complaints. This review systematically appraises and quantitatively synthesises past experimental work on the hypolipidemic capacity of the leaf extract. Five electronic databases were searched from inception to 2025; 412 records were identified, 268 screened, 74 full texts assessed and 21 studies included, of which 12 animal studies (48 dose-arms) entered the meta-analysis. Random-effects pooling showed that the leaf extract reduced serum TC by 42.7 mg/dL (95% CI: 34.5-50.9), TG by 35.4 mg/dL, LDL-C by 38.2 mg/dL and raised HDL-C by 14.6 mg/dL, with moderate heterogeneity (I-squared = 46.8%). A clear dose-response relationship was evident, with an approximate ED50 of 190 mg/kg body weight. Mechanistic data support faecal bile-acid sequestration, hepatic HMG-CoA reductase suppression, AMPK-PPAR-alpha activation and antioxidant protection. Evidence quality was nevertheless limited by small samples, non-standardised extraction, inconsistent dosing and absent toxicokinetic data. Standardised extract characterisation, marker-based dosing and Good Laboratory Practice-compliant repeat-dose toxicity studies are therefore recommended, with atherosclerotic lesion burden rather than serum lipids alone as the confirmatory endpoint, before any c
Author: Mr. Satya Prakash Pridarshi¹, Mrs. Pooja Meena², Mr Firoz Khan³ ,Dr. Kailash Kumar Pathak⁴
DOI: MJAP/05/3057
Page: 102-120
Paper Id: 3057
Publication Date: 17-Nov-2026
Download:
© 2024 MJAP. All rights reserved. Developed By Inclusion Web